Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs

Affiliations

• ¹ Botnar Research Centre, Oxford.
• ² Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
• ³ British Society for Rheumatology, London.
• ⁴ Psoriasis and Psoriatic Arthritis Alliance, St Albans.
• ⁵ Centre for Adolescent Rheumatology, Division of Medicine, University College London, London.
• ⁶ Translational Health Sciences, University of Bristol, Bristol.
• ⁷ Institute of Ophthalmology, University College London, London.
• ⁸ The Dermatology Centre, Salford Royal NHS Foundation Trust, Manchester.
• ⁹ NIHR Biomedical Research Centre, The University of Manchester, Salford.
• ¹⁰ Rheumatology Department, University Hospitals Coventry and Warwickshire NHS Trust, Coventry.
• ¹¹ Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds.
• ¹² Department of Rheumatology, Cambridge University Hospitals NHSFT.
• ¹³ Department of Medicine, University of Cambridge, Cambridge.
• ¹⁴ Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen.
• ¹⁵ Department of Rheumatology, Northern Devon Healthcare Trust.
• ¹⁶ Park House Surgery, Bagshot.
• ¹⁷ Department of Pharmacy and Pharmacology, University of Bath, Bath.
• ¹⁸ Patient Research Partner, Leeds.
• ¹⁹ Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge.
• ²⁰ Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow.
• ²¹ St John's Institute of Dermatology, Guys and St Thomas' NHS Foundation Trust and Kings College London, London.
• ²² Department of Pharmacy & Pharmacology, Centre for Therapeutic Innovation, Royal National Hospital for Rheumatic Diseases, Bath, UK.